Menxlab Announces Pre-A Funding Round of Tens of Millions RMB Led by SIG and GGV Capital
VCBeat (WeChat ID: vcbeat) has learned that on May 18, Menxlab, a men’s health management platform, announced the completion of a new Pre-A financing round amounting to tens of millions of yuan. This round was co-led by SIG and Gaorong Capital, with participation from other well-known institutions. Wave Capital continued to serve as the exclusive financial advisor for this financing round. This development comes less than three months after Menxlab announced its angel financing round.
This round of financing will continue to be allocated to independent product R&D, barrier construction, channel upgrades, and team building. Centered on data, content, and products, Menxlab will establish a digital user health lifecycle management system in the future. Meanwhile, “TimeScape,” the new personal care brand under “Menxlab Manshi,” has officially launched this month on e-commerce platforms such as Tmall.
It is reported that “Menxlab Manshi” is the first internet-based brand in China dedicated to men’s health management. Primarily targeting men aged 20–45, it addresses health concerns such as hair loss prevention and regrowth, preventive healthcare, and skincare. Through its online platform, the brand provides users with a diversified matrix of consumer-grade medical products and comprehensive service solutions.
A 2019 survey on hair loss released by the National Health Commission shows that the number of people suffering from hair loss in China has been rising sharply in recent years, exceeding 250 million. This means that one in every six people experiences hair loss, with men accounting for approximately 65%. The "White Paper on Scalp Health of Chinese People" indicates a significant trend toward younger demographics among those affected, with 84% of individuals showing signs of hair loss before the age of 30. Immense work pressure, poor dietary habits, and irregular lifestyles have contributed to health issues such as receding hairlines and hair loss among young urban males.
The domestic male health market in China is a blue ocean. Compared with Europe, the United States, and Japan, China’s consumer market is still experiencing exponential growth, with the hair loss prevention and regrowth segment alone exceeding RMB 400 billion. “Menxlab,” the first internet-based male health management brand in China, has identified pain points in the industry and taken the lead in entering the male health consumer market.
A Menxlab co-founder stated, “With the rise in male consumer awareness, an increasing number of men are paying attention to their external appearance and internal health, driving substantial demand in China’s male health market. However, due to information asymmetry, men often struggle to efficiently access effective solutions when facing health issues, potentially leading to overtreatment or unnecessary expenses. Menxlab aims to leverage the internet and new technologies to empower traditional industries, achieve information transparency and improved efficiency, and provide users with safer and more stable solutions.”
Facing the vast population suffering from hair loss and significant market demand, Menxlab enters the niche segment of hair care products to provide a comprehensive solution for individuals with hair loss. For users in the early to middle stages of hair loss, basic hair care products and scalp treatment serums are available to help slow down hair loss and promote new hair growth.
Menxlab has launched its personal care brand, “Shiguang Li” (In the Flow of Time), which includes products such as shampoo and hair growth serum, suitable for both male and female users. Its Tmall flagship store, “Shiguang Li Flagship,” opened on May 18 and has simultaneously introduced the “Shiguang Li” shampoo, with additional products like the new hair growth serum to be rolled out subsequently. The “Shiguang Li” brand aims to lower the financial barrier for consumers while alleviating anxiety and psychological burden associated with product use, thereby better improving scalp health.
When asked about the design inspiration behind “Shiguang Li,” a co-founder of Menxlab explained, “The shape of Shiguang Li shampoo is derived from the ‘X’ in Menxlab. The container features an hourglass silhouette, symbolizing the desire to hold back time and let the years pass more slowly. As we started our business in Guangzhou, we aimed to create iconic, high-value products. Thus, the Shiguang Li shampoo, which closely resembles the Canton Tower, is affectionately known as ‘Xiao Manyao.’”
In terms of patents, the company’s R&D team possesses patented formula ingredients and utilizes a patented nanocarrier anti-hair-loss delivery technology jointly developed by Huazhong University of Science and Technology and the National Center for Nanoscience and Engineering. This technology enables more effective penetration and sustained release of active anti-hair-loss ingredients, thereby enhancing hair loss prevention and regrowth outcomes. “The molecular structure of the core anti-hair-loss ingredient in Timeless products is highly similar to that of minoxidil, offering comparable efficacy while demonstrating superior water solubility. It is an internationally certified patented anti-hair-loss ingredient approved for use in hair care and cleansing products,” revealed a co-founder of Menxlab.
Furthermore, to address pathological hair loss conditions such as severe receding hairlines, Menxlab offers a professional-grade product portfolio and consulting services. By leveraging pharmaceuticals like minoxidil and finasteride, along with medical devices, it achieves anti-hair loss and hair regrowth effects, ultimately realizing an integrated approach of early prevention and mid-stage treatment. While providing specialized solutions for hair loss and regrowth, “Menxlab Manshi” is continuously enhancing its men’s health product series and APP mini-program, centered on the convergence of medical healthcare and male consumption upgrading, thereby building a professional-grade consumer platform for medical healthcare.
Regarding the investment rationale for this funding round, SIG investor Wang Zhenye stated, “We believe that the pursuit of a healthy and high-quality lifestyle is a long-term, sustained macro trend. However, there remains a significant supply-demand gap in the domestic male market, particularly in China, presenting substantial opportunities for domestic brands. As a company with strong product R&D capabilities, sales and operational expertise, and a distinct brand identity, we are confident that ‘Menxlab’ will stand out from the competition.”